Increased cystatin C in astrocytes of transgenic mice expressing the K670N-M671L mutation of the amyloid precursor protein and deposition in brain amyloid plaques
T. Steinhoff et al., Increased cystatin C in astrocytes of transgenic mice expressing the K670N-M671L mutation of the amyloid precursor protein and deposition in brain amyloid plaques, NEUROBIOL D, 8(4), 2001, pp. 647-654
Cystatin C is an essential secretory cofactor for neurogenesis with potent
protease inhibitor activities. Polymorphisms of cystatin C are genetically
associated with Alzheimer's disease (AD), and the L68Q mutation causes here
ditary cerebral hemorrhage with amyloidosis of the Icelandic type, in which
cystatin C and beta -amyloid are colocalized in cortical blood vessels. To
determine whether cystatin C and beta -amyloid also colocalize in brain am
yloid plaques, we analyzed transgenic mice expressing the Swedish APP (SweA
PP) mutation. We found high levels of cystatin C in astrocytes surrounding
beta -amyloid plaques, and discrete layers of cystatin C attached to amyloi
d plaque cores covered by a layer of beta -amyloid. In addition, cystatin C
accumulated in reactive astrocytes throughout the brain, independently of,
and before the onset of, amyloid plaque formation. These results show that
expression of SweAPP is associated with increased cystatin C in reactive a
strocytes, and they suggest an early role of cystatin C in appositional amy
loid plaque growth. (C) 2001 Academic Press.